NCT05353452

Brief Summary

The purpose of this research is to evaluate a 6 month change in quality of life in subjects who receive collaborative care calls compared to those subjects who receive usual neurology care. This is a 2-site trial comparing a 24 week neurology-based collaborative care program to usual neurology care among a total of 60 adults with post-traumatic epilepsy.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
2mo left

Started Apr 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress95%
Apr 2023Jul 2026

First Submitted

Initial submission to the registry

April 25, 2022

Completed
4 days until next milestone

First Posted

Study publicly available on registry

April 29, 2022

Completed
1 year until next milestone

Study Start

First participant enrolled

April 30, 2023

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2026

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2026

Expected
Last Updated

February 3, 2026

Status Verified

January 1, 2026

Enrollment Period

3 years

First QC Date

April 25, 2022

Last Update Submit

January 30, 2026

Conditions

Keywords

epilepsyneurological carecollaborative careanxietydepression

Outcome Measures

Primary Outcomes (1)

  • Emotional Subscale-Change in Quality of Life in Epilepsy-31(QOLIE-31)

    This is a clinically meaningful patient reported outcome measure that was demonstrated to improve in collaborative care efficacy trials in distinct patient groups (including with various different types of medical illness) Score ranges from 0-100 with higher score indicating better quality of life

    Baseline through Month 6

Secondary Outcomes (4)

  • Subject Adherence to Intervention

    Week 12

  • Change in Epilepsy specific QOLIE-31 score

    Baseline through Month 6

  • Change in Beck Depression Inventory-II (BDI-II) score

    From baseline through Month 6

  • Change in Beck Anxiety Index (BAI) score

    From baseline through Month 6

Other Outcomes (22)

  • Feasibility of Intervention Measure (FIM)-Subject Perspective

    Baseline and Month 3

  • FIM-Neurologist Perspective

    Baseline and Month 3

  • Acceptability of Intervention Measure (AIM)-Subject Perspective

    Baseline and Month 3

  • +19 more other outcomes

Study Arms (2)

Collaborative Care

EXPERIMENTAL

Participants in this arm will receive 24 weeks of neurology based collaborative care.

Behavioral: Neurology Based Collaborative Care

Standard of Care (SOC)

ACTIVE COMPARATOR

Participants in this arm will receive provider-recommended clinic visits, prescriptions, testing, and referrals.

Behavioral: SOC Neurological care

Interventions

Usual neurology care means ongoing, epilepsy provider-recommended clinic visits, prescriptions, testing and referrals from their epilepsy provider. Mental health referrals or prescribing of antidepressants may potentially occur in this group; these types of interventions will be tracked at outcome assessments.

Standard of Care (SOC)

Twenty-four week, evidence-based remote collaborative care model initiated around the time of a neurology visit. The collaborative care team roles include the care manager, psychiatrist, and psychologist/social worker who interact with the patient participant and the patient's neurologist.

Collaborative Care

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Provision of signed and dated informed consent form
  • Stated willingness to comply with all study procedures
  • Diagnosis of post-traumatic epilepsy, defined by the following:
  • Epilepsy diagnosis based on neurology clinician impression of diagnosis or electroencephalogram (EEG) findings (EEG findings: presence of interictal epileptiform discharges on EEG or ictal EEG recording of seizure definitively documenting epilepsy diagnosis)
  • History of at least mild traumatic brain injury based on the MIRECC (Mental Illness Research, Education, and Clinical Center) TBI (Traumatic Brain Injury) screening instrument or verified TBI history based on MIRECC research database
  • TBI pre-dated onset of epilepsy (NINDS post-traumatic epilepsy screening form)
  • Anxiety or depression symptoms--Generalized Anxiety Disorder scale (GAD-7) ≥8 or Neurological Disorders Depression Inventory for Epilepsy (NDDI-E) \>13
  • Receiving clinical neurological care at one of the study sites

You may not qualify if:

  • Active ongoing treatment by a psychiatrist without the potential to benefit from additional collaborative care for anxiety or depression in the judgement of the investigators
  • Active suicidal ideation
  • History of past suicide attempt
  • Unstable drug or alcohol abuse
  • Unstable or progressive comorbid medical condition
  • Current participation in another treatment or intervention study
  • Cognitive limitations precluding completion of anxiety and depression self-report instruments on paper, electronically, or by interview.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Atrium Health Wake Forest Baptist

Winston-Salem, North Carolina, 27157, United States

RECRUITING

Related Publications (1)

  • Munger Clary HM, Snively BM, Cagle C, Kennerly R, Kimball JN, Alexander HB, Brenes GA, Moore JB, Hurley RA. Collaborative Care to Improve Quality of Life for Anxiety and Depression in Posttraumatic Epilepsy (CoCarePTE): Protocol for a Randomized Hybrid Effectiveness-Implementation Trial. JMIR Res Protoc. 2024 Nov 13;13:e59329. doi: 10.2196/59329.

MeSH Terms

Conditions

Epilepsy, Post-TraumaticEpilepsyAnxiety DisordersDepression

Condition Hierarchy (Ancestors)

Brain InjuriesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesCraniocerebral TraumaTrauma, Nervous SystemWounds and InjuriesMental DisordersBehavioral SymptomsBehavior

Study Officials

  • Heidi M. Munger Clary, MD, MPH

    Atrium Health Wake Forest Baptist

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Heidi M. Munger Clary, MD, MPH

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 25, 2022

First Posted

April 29, 2022

Study Start

April 30, 2023

Primary Completion

May 1, 2026

Study Completion (Estimated)

July 1, 2026

Last Updated

February 3, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

Locations